REG - Syncona Limited - Issue of shares pursuant to incentive scheme

SynconaAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251117:nRSQ6685Ha&default-theme=true

RNS Number : 6685H  Syncona Limited  17 November 2025

Syncona Limited

Issue of shares pursuant to incentive scheme

17 November 2025

Syncona Ltd (the "Company"), a leading life science investor, today announces
that a total of 334,788 new ordinary shares (representing approximately
0.055% of the Company's existing issued ordinary shares, excluding shares held
in treasury) will be issued in satisfaction of realisations under the
Company's long term incentive scheme.  The new ordinary shares, when issued,
will rank pari passu with the existing issued ordinary shares of the
Company. In accordance with the rules of the incentive scheme, the number of
ordinary shares to be issued has been calculated using the closing mid-market
price on 13 November 2025, £0.996 per ordinary share in the Company.

In accordance with the rules of the incentive scheme, ordinary shares
delivered on realisation may not be sold or transferred by the recipient for a
period of one year following the realisation date.

Application will be made to the Financial Conduct Authority for the shares to
be admitted to the Official List and to the London Stock Exchange for the
shares to be admitted to trading. It is expected that dealings will commence
in the new ordinary shares on 20 November 2025.

 ENDS 

 

Enquiries

 

Syncona Ltd

 

Annabel Clark

Tel: +44 (0) 20 3981 7940

 

Copies of this press release and other corporate information can be found on
the company website at: www.synconaltd.com (http://www.synconaltd.com/)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ALSEAKFLFLPSFFA



            Copyright 2019 Regulatory News Service, all rights reserved